| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
Section of Hematology-Oncology, Department of Medicine [Y. C., M. H. W., M. E. D.] and Cancer Research Center [M. E. D.], University of Chicago, Chicago, Illinois 60637; Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033 [M. X-W., A. E. P.]; and Duke Comprehensive Cancer Center, Duke University, Durham, North Carolina 27710 [S. M. L.]
The DNA repair protein O6-alkylguanine-DNA alkyltransferase (AGT) has been shown to protect cells from the toxic and mutagenic effect of alkylating agents by removing lesions from the O6 position of guanine. O6-Benzylguanine (BG) is a potent inactivator of AGT, resulting in an increase in the sensitivity of cells to the toxic effects of chemotherapeutic alkylating agents. Chinese hamster ovary (CHO) cells and CHO cells transfected with wild-type AGT (CHOWTAGT) and a mutant AGT [P138 M/V139I/P140K (CHOMIK)] known to be resistant to BG were treated with BG and various alkylating agents. BG treatment alone dramatically decreased AGT activity in CHOWTAGT cells but resulted in no depletion in AGT activity in CHOMIK cells. In the absence of AGT, these cells are highly sensitive to the toxic and mutagenic effects of temozolomide and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), and no further sensitization occurs in the presence of BG. In contrast, CHOWTAGT cells are resistant to temozolomide and BCNU, and treatment with BG resulted in a significantly higher cell killing and mutation frequency. CHOMIK cells were completely resistant to temozolomide or BCNU in the presence and absence of BG. Both cell killing and mutation frequency of 4-hydroperoxycyclophosphamide (4-HC) in CHO, CHOWTAGT, and CHOMIK cells were increased in the presence of BG. 4-HC generates two active metabolites, phosphoramide mustard (PM) and acrolein. BG had no effect on 4-hydroperoxydidechlorocyclophosphamide (which generates acrolein and a nonalkylating form of PM) in CHO cells and CHOMIK cells, but enhancement of toxicity was observed with PM in both these cell lines. Therefore, we attribute the enhancement to the PM metabolite of 4-HC. Our results demonstrate that wild-type AGT plays an important role in protecting against the toxic and mutagenic effect of O6 alkylating agents and that a mutant AGT resistant to inactivation by BG effectively prevents BG-enhanced toxicity and mutagenicity induced by these agents. Expression of the AGT protein contributes to resistance of 4-HC. BG also enhances the toxicity of 4-HC and PM by a mechanism that may not involve the AGT repair protein.
This article has been cited by other articles:
![]() |
J. N. Sarkaria, G. J. Kitange, C. D. James, R. Plummer, H. Calvert, M. Weller, and W. Wick Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma Clin. Cancer Res., May 15, 2008; 14(10): 2900 - 2908. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yamini, X. Yu, M. E. Dolan, M. H. Wu, D. W. Kufe, and R. R. Weichselbaum Inhibition of Nuclear Factor-{kappa}B Activity by Temozolomide Involves O6-Methylguanine Induced Inhibition of p65 DNA Binding Cancer Res., July 15, 2007; 67(14): 6889 - 6898. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Hansen, R. Nagasubramanian, S. M. Delaney, L. D. Samson, and M.E. Dolan Role of O6-methylguanine-DNA methyltransferase in protecting from alkylating agent-induced toxicity and mutations in mice Carcinogenesis, May 1, 2007; 28(5): 1111 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Desmeules and P. J. Devine Characterizing the Ovotoxicity of Cyclophosphamide Metabolites on Cultured Mouse Ovaries Toxicol. Sci., April 1, 2006; 90(2): 500 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Paz, R. Yaya-Tur, I. Rojas-Marcos, G. Reynes, M. Pollan, L. Aguirre-Cruz, J. L. Garcia-Lopez, J. Piquer, M.-J. Safont, C. Balana, et al. CpG Island Hypermethylation of the DNA Repair Enzyme Methyltransferase Predicts Response to Temozolomide in Primary Gliomas Clin. Cancer Res., August 1, 2004; 10(15): 4933 - 4938. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Fishel, S. M. Delaney, L. D. Friesen, R. J. Hansen, E. G. Zuhowski, R. C. Moschel, M. J. Egorin, and M. E. Dolan Enhancement of Platinum-induced Cytotoxicity by O6-Benzylguanine Mol. Cancer Ther., July 1, 2003; 2(7): 633 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Bodell, N. W. Gaikwad, D. Miller, and M. S. Berger Formation of DNA Adducts and Induction of lacI Mutations in Big Blue Rat-2 Cells Treated with Temozolomide: Implications for the Treatment of Low-Grade Adult and Pediatric Brain Tumors Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 545 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Morvan, A. Demidem, J. Papon, M. De Latour, and J. C. Madelmont Melanoma Tumors Acquire a New Phospholipid Metabolism Phenotype under Cystemustine As Revealed by High-Resolution Magic Angle Spinning Proton Nuclear Magnetic Resonance Spectroscopy of Intact Tumor Samples Cancer Res., March 1, 2002; 62(6): 1890 - 1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Dolan and R. L. Schilsky Silence Is Golden: Gene Hypermethylation and Survival in Large-Cell Lymphoma J Natl Cancer Inst, January 2, 2002; 94(1): 6 - 7. [Full Text] [PDF] |
||||
![]() |
M. Esteller, G. Gaidano, S. N. Goodman, V. Zagonel, D. Capello, B. Botto, D. Rossi, A. Gloghini, U. Vitolo, A. Carbone, et al. Hypermethylation of the DNA Repair Gene O6-Methylguanine DNA Methyltransferase and Survival of Patients With Diffuse Large B-Cell Lymphoma J Natl Cancer Inst, January 2, 2002; 94(1): 26 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cai, S. M. Ludeman, L. R. Wilson, A. B. Chung, and M. E. Dolan Effect of O6-Benzylguanine on Nitrogen Mustard-induced Toxicity, Apoptosis, and Mutagenicity in Chinese Hamster Ovary Cells Mol. Cancer Ther., November 1, 2001; 1(1): 21 - 28. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |